首页 | 本学科首页   官方微博 | 高级检索  
   检索      


ATP sensitive bi-quinoline activator of the AMP-activated protein kinase
Authors:John W Scott  Jonathan S Oakhill  Naomi XY Ling  Christopher G Langendorf  Richard C Foitzik  Bruce E Kemp  Olaf-Georg Issinger
Institution:1. St. Vincent’s Institute and Department of Medicine, University of Melbourne, 41 Victoria Parade, Fitzroy 3065, Victoria, Australia;2. Cancer Therapeutics CRC Pty. Ltd., Medicinal Chemistry and Drug Action, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia;3. Biomedical Research Group, BMB, University of Southern Denmark, Campusvej 55, 5230 Odense, Denmark
Abstract:The AMP-activated protein kinase (AMPK) regulates cellular and whole-body energy balance in response to changes in adenylate charge and hormonal signals. Activation of AMPK in tissues such as skeletal muscle and liver reverses many of the metabolic defects associated with obesity and Type 2 diabetes. Here we report a bi-quinoline (JJO-1) that allosterically activates all AMPK αβγ isoforms in vitro except complexes containing the γ3 subunit. JJO-1 does not directly activate the autoinhibited α subunit kinase domain and differs among other known direct activators of AMPK in that allosteric activation occurs only at low ATP concentrations, and is not influenced by either mutation of the γ subunit adenylate-nucleotide binding sites or deletion of the β subunit carbohydrate-binding module. Our findings indicate that AMPK has multiple modes of allosteric activation that may be exploited to design isoform-specific activators as potential therapeutics for metabolic diseases.
Keywords:AMPK  Allosteric  Drug  Activator  Phosphorylation  Isoform-specific
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号